Abstract:Introduction: Inflammatory bowel diseases (IBD) are multifactorial, chronic, continuous, relapsing, and immune-mediated diseases of the gastrointestinal tract. The pathogenesis of IBD is linked to genetically susceptible individuals, dysregulated gut microbiota (dysbiosis), chronic inflammation, and poor dietary patterns. Diet and microRNAs/exosomes play an important role in modulating the intestinal microbiota, and can be applied as a therapeutic tool to improve the course of IBD. Objective: It was to carry out a systematic review of the main considerations of nutrological aspects, intestinal microbiota, and the regulation (Down or Up-regulation) and modulation of microRNAs/exosomes in inflammatory bowel diseases. Methods: The present study followed the international model of systematic review and meta-analysis (PRISMA). Clinical studies were included, involving randomized controlled, prospective, and retrospective studies, as well as pre-clinical studies, published in previous years as gold standard articles until 2023. Results and Conclusion: A total of 154 articles were found. A total of 78 articles were fully evaluated and 55 were included in this systematic review. Considering the Cochrane tool for risk of bias, 22 studies with a high risk of bias and 24 studies that did not meet the GRADE were removed. Most studies showed homogeneity in their results, with X2 =93.5% >50%. The present study analyzed the main interactions between dietary therapy, intestinal microbiota, microRNAs, exosomes, and inflammatory bowel disease, elucidating the main clinical outcomes of the disease after nutrological treatment. As a corollary, important randomized controlled clinical studies were found in the last ten years that showed the important role of diet modulation in the control and even in the remission of inflammatory bowel disease, revealing important reductions in persistent intestinal symptoms, in the balance of the intestinal microbiota, in the regulatory role of microRNAs, reducing inflammation markers and improving quality of life. Recognition of the need for additional data from clinical trials, the inherent uncertainty of efficacy for all inflammatory bowel disease therapies, and the potential for benefit with dietary interventions will help guide progress toward a better understanding of the usefulness of dietary therapy for individuals with inflammatory bowel disease.

Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review

The role of miRNA in IBS pathogenesis, diagnosis and therapy: The latest thought

Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis

Role of miRNAs in pathogenesis of inflammatory bowel disease

Potential neuro-immune therapeutic targets in irritable bowel syndrome

Implication of Mirnas for Inflammatory Bowel Disease Treatment:Systematic Review

Role of MicroRNAs in Regulating T Cell Responses in Inflammatory Bowel Disease

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis

MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?

MicroRNAs As Potential Biomarkers for the Diagnosis of Inflammatory Bowel Disease: a Systematic Review and Meta-Analysis

Exploring the clinical significance of miR‐148 expression variations in distinct subtypes of irritable bowel syndrome

MicroRNA signatures in the pathogenesis and therapy of inflammatory bowel disease

A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers

Micrornas As Therapeutic Targets in Intestinal Diseases

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome

MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression

Gut Microbiota and Irritable Bowel Syndrome: Status and Prospect

Major considerations of nutrological aspects, gut microbiota, and regulation (down or up-regulation) of microRNAs/exosomes in inflammatory bowel diseases: a systematic review

Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review

Identification and potential functions of tRNA-derived small RNAs (tsRNAs) in irritable bowel syndrome with diarrhea